Roginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL)
for Leukemia
Drug: Venetoclax
1 location in Boston
Sponsor: Jennifer R. Brown, MD, PhD
Sex: All·Age: 18+
Code: NCT06644183·Phase 1, Phase 2·Recruiting